National Bank of Canada’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.07M Sell
5,801
-766
-12% -$354K ﹤0.01% 1030
2026
Q1
$3.15M Sell
6,567
-3,156
-32% -$1.62M ﹤0.01% 973
2025
Q4
$5.46M Buy
+9,723
New +$5.52M 0.01% 858
2024
Q4
Sell
-107
Closed -$35.7K 3106
2024
Q3
$35.7K Sell
107
-25
-19% -$9.5K ﹤0.01% 1799
2024
Q2
$53.8K Sell
132
-1,511
-92% -$598K ﹤0.01% 1666
2024
Q1
$641K Buy
1,643
+1,613
+5,377% +$567K ﹤0.01% 1204
2023
Q4
$9.16K Hold
30
﹤0.01% 2189
2023
Q3
$7.27K Hold
30
﹤0.01% 2275
2023
Q2
$7.2K Sell
30
-95
-76% -$19.7K ﹤0.01% 2266
2023
Q1
$23.5K Sell
125
-250
-67% -$51.7K ﹤0.01% 1920
2022
Q4
$79.6K Buy
375
+345
+1,150% +$68.9K ﹤0.01% 1624
2022
Q3
$5K Hold
30
﹤0.01% 2340
2022
Q2
$4K Hold
30
﹤0.01% 2473
2022
Q1
$5K Hold
30
﹤0.01% 2552
2021
Q4
$7K Buy
+30
New +$6.28K ﹤0.01% 2463

Other funds holding MEDP

National Bank of Canada's MEDP Position: Q2 2026 in Review

National Bank of Canada reduced its Medpace (MEDP) stake by 12% in Q2 2026, selling an estimated $354K and leaving 5,801 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

National Bank of Canada first reported a position in MEDP in Q4 2021 and has held it in 15 quarters since. The position peaked at $5.46M in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • National Bank of Canada held 5,801 shares of Medpace worth $3.07M as of Q2 2026.
  • National Bank of Canada sold 766 Medpace shares in Q2 2026, an estimated $354K.
  • Medpace made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #1030 holding.
  • National Bank of Canada first reported a position in Medpace in Q4 2021 and has held it in 15 quarters since.
  • National Bank of Canada's Medpace position peaked at $5.46M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.